Pertussis is a highly contagious disease of the respiratory tract caused by Bordetella pertussis, a bacteria that lives in the mouth, nose, and throat. Many children who contract pertussis have coughing spells that last four to eight weeks. The disease is most dangerous in infants and spreads easily from person to person, mainly through droplets produced by coughing or sneezing. The first symptoms generally appear 7–10 days after infection, and include mild fever, runny nose, and cough, which in typical cases gradually develops into a paroxysmal cough followed by whooping (hence the common name of whooping cough). In the youngest infants, the paroxysms may be followed by periods of apnoea. Pneumonia is a relatively common complication; seizures and encephalopathy occur more rarely. Untreated patients may be contagious for three weeks or more following onset of the cough. Pertussis can be prevented by immunization.
For several decades, infant immunization programmes around the world have been highly successful in using pertussis vaccines of documented quality to prevent severe pertussis in infants. WHO estimates that in 2008 global vaccination against pertussis prevented approximately 687 000 deaths.
The main aim of pertussis vaccination is to reduce the risk of severe pertussis in infancy. To this end, the ongoing priority of immunization programmes worldwide is to vaccinate at least 90 percent of infants with three doses of high-quality pertussis vaccine.
Although vaccination can prevent pertussis in adolescents and adults, there is insufficient evidence that vaccine boosters in these age groups can reduce severe pertussis in infants. When a country implements a programme for adults, vaccination of health care workers should be prioritized, especially those with direct contact with pregnant mothers and infant patients. Vaccination of pregnant women is likely to be the most cost-effective additional strategy for preventing disease in infants too young to be vaccinated and appears to be more effective and favourable than cocooning.
WHO position paper
- Data on pertussis cases, estimated deaths and vaccination coverage
- The Immunological Basis for Immunization Series. Pertussis (2009) [pdf 2.04Mb]
Information sheet on the observed rate of vaccine reactions for diphtheria, pertussis and tetanus vaccines
Last updated: 4 September 2015
Calls for consultants / proposals
SAGE call for nominations
Invitation to monitoring and evaluation companies to submit an Expression of Interest (EOI) for monitoring for the WHO led MVPE
Systematic review and meta-analysis of the population-level impact and herd effects following human papillomavirus immunization programmes and potential for HPV elimination